Cinctive Capital Management LP Buys New Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Cinctive Capital Management LP invested approximately $5.34 million in HCA Healthcare by purchasing 15,448 shares during the first quarter.
• Institutional investors hold 62.73% of HCA Healthcare's stock, with several firms like Ameriprise Financial and Baird Financial increasing their stakes recently.
• HCA Healthcare reported a net income of $6.84 per share for the quarter, exceeding analysts' expectations, with a revenue of $18.61 billion.

Cinctive Capital Management LP bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 15,448 shares of the company's stock, valued at approximately $5,338,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Cheviot Value Management LLC acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare in the 1st quarter worth approximately $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare during the first quarter worth approximately $27,000. Atwood & Palmer Inc. purchased a new stake in shares of HCA Healthcare during the first quarter valued at approximately $28,000. Finally, Bartlett & CO. Wealth Management LLC increased its holdings in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after acquiring an additional 80 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 2.2%

NYSE:HCA traded up $9.09 during trading hours on Friday, reaching $420.68. The company's stock had a trading volume of 1,059,770 shares, compared to its average volume of 1,054,336. The firm has a market capitalization of $98.43 billion, a price-to-earnings ratio of 17.68, a PEG ratio of 1.32 and a beta of 1.41. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $420.98. The firm has a 50-day simple moving average of $380.14 and a 200-day simple moving average of $360.12. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same period in the previous year, the company earned $5.50 earnings per share. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Royal Bank Of Canada cut their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Cantor Fitzgerald restated an "overweight" rating and issued a $444.00 price target on shares of HCA Healthcare in a research note on Tuesday, August 26th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.